Bydureon Pancreatic Cancer Lawsuits
In Bydureon pancreatic cancer lawsuits, victims are eligible to recover just compensation for their damages, including medical bills, lost wages, and pain and suffering. Bydureon is a drug prescribed to help patients with type-2 diabetes regulate their blood sugar, and it has been associated with a heightened risk for developing pancreatitis and pancreatic cancer. To learn more about victims’ rights in Bydureon pancreatic cancer lawsuits, we invite you to contact Arentz Law Group, P.C. to schedule a free consultation with an experienced dangerous drug lawyer.
Bydureon Overview
Bydureon was approved by the FDA in 2012 as a treatment for type-2 diabetes. Bydureon is a once-weekly version of the drug Byetta (approved in 2005), and both drugs are made by Amylin Pharmaceuticals. Bydureon is a member of the glucagon-like peptide-1 family of diabetes drugs, and it helps patients achieve lover blood sugar levels by stimulating insulin secretion in the pancreas.
Bydureon Pancreatic Cancer
The FDA first posted Byetta pancretitis warnings in 2007, just two years after the drug was released. At this point, the agency had already received more than 30 reports of acute pancreatitis linked to use of Byetta. There were also numerous reports of hemorrhagic pancreatitis and necrotizing pancreatitis in Byetta patients, and both of these conditions can lead to organ failure and death. Research has shown that the longer a patient uses Byetta or Bydureon, the higher his or her risk of developing pancreatitis becomes.
Chronic pancreatits has been linked to the development of pancreatic cancer, the fourth most deadly cancer in the United States. Fewer than 5% of patients diagnosed with pancreatic cancer survive more than 5 years after diagnosis.
Contact a Bydureon Pancreatic Cancer Lawsuit Attorney
A number of victims of Bydureon pancreatic cancer have filed lawsuits against Amylin Pharmaceuticals, claiming that the pharmaceutical knew of the risk of Bydureon pancreatic cancer but failed to post sufficient warnings about this risk in the interest of protecting their profits. If you or someone you love has been diagnosed with pancreatitis or pancreatic cancer that you believe may be linked to use of Bydureon or a similar diabetes drug, we encourage you to learn more about your rights. Contact us to schedule a free Bydureon pancreatic cancer lawsuit with an experienced member of our pharmaceutical product liability team.